- Product Details
Keywords
- 3382-63-6
- 4-[[(4-FLUOROPHENYL)IMINO METHYL -PHENOL 99%
- intermediate of Ezetimibe
Quick Details
- ProName: 3382-63-6 4-[[(4-FLUOROPHENYL)IMIN...
- CasNo: 3382-63-6
- Molecular Formula: C13H10FNO
- Appearance: Yellow or off yellow solid
- Application: intermediate of Ezetimibe
- DeliveryTime: ready stock
- PackAge: according to the clients requirement
- ProductionCapacity: 3000 Kilogram/Month
- Purity: 99%min
- Storage: room temperature,away from sunlight
- Transportation: by air or by sea
- LimitNum: 25 Kilogram
- Moisture Content: NMT 0.5%
- Impurity: Single impurity NMT 0.5%
Superiority
Mature product Manufacturer of Ezetimibe
Standard: in house standard
Assay: 98%min
Time of delivery: ready stock
Package: according to the clients requirement
1.Place of Origin China with Super quality by reasonable price.
2.Fast delivery by safe express way to all the country.
3.Has a number of highly qualified engineers and experts to provide guidance for reagents.
4.When you meet problems in mineral processing, we can provide technical guidance.
5. Sample order are welcome.
Details
Arbidol hydrochloride; Isosorbide-5-mononitrate; Loxoprofen sodium; Ezetimibe; Amisulpride; Mildronate; Atazanavir; Raltitrexed
4-[[(4-Fluorophenyl)imino]methyl]-phenol Basic information |
Product Name: | 4-[[(4-Fluorophenyl)imino]methyl]-phenol |
Synonyms: | 4-(4-HYDROXYBENZYLIDENE) FLUORO ANILINE;4-(((4-FLUOROPHENYL)IMINO)METHYL)PHENOL;2-(4 ' -Hydrophenyl)-4-fluorobenyl imine;alpha-4-Fluorophenylimino-p-cresol;(E)-4-((4-Fluorophenylimino)methyl)phenol;4-fluoro-N-(hydroxyphenyl)methylene-benzenamine;E2:4{[(4-fluorophenyl)imino]methyl}phenol;Phenol, 4-[[(4-fluorophenyl)iMino]Methyl]- |
CAS: | 3382-63-6 |
MF: | C13H10FNO |
MW: | 215.22 |
EINECS: | |
Product Categories: | Intermediate of ezetimibe;Ezetimibe INTERMEDIATES |
Mol File: | 3382-63-6.mol |
|
Chemical Properties | Pale Yellow Solid |
Usage | 4-{[(p-Fluorophenyl)imino]methyl}phenol is used in the preparation of benzylacetones which promote anti-fungal activity. |